iNtRON Biotechnology, Inc.
Industry
- Digital Health
- Disease Management
- Biotechnology
- Drug Discovery Technologies
- Pharmaceuticals
Other Names/Subsidiaries
- iNtODEWORLD
Latest on iNtRON Biotechnology, Inc.
Basilea Pharmaceutica Ltd. has secured a transformational approval across the Atlantic for Zevtera nearly 15 years after the US Food and Drug Administration rejected the Swiss biotech's antibiotic. T
After a busy 2023 on the business development front, Basilea Pharmaceutica Ltd. has started the year by adding more assets to its pipeline with the acquisition of a preclinical antibiotics program f
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Partners With Verve Again By Acqu
Out-licensing deals by South Korean companies picked up speed in 2018 after relative sluggishness in the past couple of years. Large out-licensing transactions by biotechs noticeably increased, reflec